Diagnosis and management of left ventricular diastolic dysfunction in the hypertensive patient

American Journal of Hypertension

Volumn 24, Issue 5, 2011, Pages 507-517

  Galderisi, Maurizio ^a  

^a FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

arterial hypertension; blood pressure; diastolic dysfunction; heart failure with normal ejection fraction; hypertension; left ventricular filling pressure; renin angiotensin aldosterone system

Indexed keywords

ALDOSTERONE ANTAGONIST; ALISKIREN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CANRENONE; CARDIOVASCULAR AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; EPLERENONE; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; IVRABADINE; NEBIVOLOL; PERINDOPRIL; RAMIPRIL; RANOLAZINE; SPIRONOLACTONE; TELMISARTAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALSARTAN; VERAPAMIL;

ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR PARAMETERS; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; HEART FAILURE; HEART FAILURE WITH NORMAL EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE DIASTOLIC DYSFUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM RESTRICTION;

CLINICAL TRIALS AS TOPIC; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; HUMANS; HYPERTENSION; STROKE VOLUME; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79954961345     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2010.235     Document Type: Article

References (101)

1. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996; 275:1557-1562. (Pubitemid 26154241)
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566. (Pubitemid 20176696)
3. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114:345-352.
4. Verdecchia P, Schillaci G, Borgio C, Ciucci A, Battistelli M, Bartoccini C, Santucci A, Santucci C, Reboldi G, Porcellati C. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass J Am Coll Cardiol 1995; 25:871-878.
5. Fouad FM, Slominski JM, Tarazi RC. Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function J Am Coll Cardiol 1984; 3:1500-1506. (Pubitemid 14110106)
6. Aeschbacher BC, Hutter D, Fuhrer J, Weidmann P, Delacrétaz E, Allemann Y. Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens 2001; 14:106-113. (Pubitemid 32171561)
7. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prog nosis J Am Coll Cardiol 2004; 43:317-327. (Pubitemid 38167688)
8. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355:251-259. (Pubitemid 44079340)
9. Spinale FG. Bioactive peptide signaling within the myocardial interstitium and the matrix metalloproteinases. Circ Res 2002;91:1082-1084. (Pubitemid 36076354)
10. Takeda Y, Zhu A, Yoneda T, Usukura M, Takata H, Yamagishi M. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats. Am J Hypertens 2007; 20:1119-1124 (Pubitemid 47446168)
11. MacKenna D, Summerour SR, Villarreal FJ. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovasc Res 2000; 46:257-263. (Pubitemid 30204597)
12. Galderisi M, Benjamin EJ, Evans JC, D'Agostino RB, Fuller DL, Lehman B, Wolf PA, Levy D. Intra-and interobserver reproducibility of Doppler-assessed indexes of eft ventricular diastolic function in a population-based study (the Framingham Heart Study). Am J Cardiol 1992; 70:1341-1346.
13. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone J Am Coll Cardiol 1997; 30:8-18. (Pubitemid 27357121)
14. Lester SJ, Tajik AJ, Nishimura RA, Oh JK, Khandheria BK, Seward JB. Unlocking the mysteries of diastolic function: deciphering the Rosetta Stone 10 years later J Am Coll Cardiol 2008; 51:679-689. (Pubitemid 351221211)
15. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography J Am Soc Echocardiogr 2009; 22:107-133.
16. Shan K, Bick RJ, Poindexter BJ, Shimoni S, Letsou GV, Reardon MJ, Howell JF, Zoghbi WA, Nagueh SF Relation of tissue Doppler derived myocardial velocities to myocardial structure and β-adrenergic receptor density in humans J Am Coll Cardiol 2000; 36:891-896.
17. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation 2000; 102:1788-1794.
18. Nagueh SF, Mikati I, Kopelen HA, Middleton KJ, Quiñones MA, Zoghbi WA. Doppler estimation of left ventricular filling pressure in sinus tachycardia. A new application of tissue doppler imaging. Circulation 1998; 98:1644-1650. (Pubitemid 28500387)
19. Nagueh SF, Kopelen HA, Quiñones MA. Assessment of left ventricular filling pressures by Doppler in the presence of atrial fibrillation. Circulation 1996; 94:2138-2145. (Pubitemid 26360506)
20. Tsang TS, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ, Bailey KR, Cha SS, Seward JB. Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? J Am Coll Cardiol 2006; 47:1018-1023.
21. Di Bello V, Talarico L, Picano E, Di Muro C, Landini L, Paterni M, Matteucci E, Giusti C, Giampietro O. Increased echo of myocardial wal in the diabetic heart: an ultrasound tissue characterization study J Am Coll Cardiol 1995; 25:1408-1415.
22. Maceira AM, Barba J, Varo N Ultrasonic backscatter and serum marker of cardiac fibro s in hypertensives. Hypertension 2002; 39:923-928. (Pubitemid 34437551)
23. Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, Nesser HJ, Khandheria B, Narula J, Sengupta PP. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications J Am Soc Echocardiogr 2010; 23:351-69; quiz 453.
24. de Simone G, Izzo R, Chinali M, De Marco M, Casalnuovo G, Rozza F, Girfoglio D, ovino GL, Trimarco B, De Luca N. Does information on systolic and d stolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? Hypertension 2010; 56:99-104.
25. Schillaci G, Pasqualini L, Verdecchia P, Vaudo G, Marchesi S, Porcellati C, de Simone G, Mannarino E. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol 2002; 39:2005-2011. (Pubitemid 34628283)
26. Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kitzman D. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study J Am Coll Cardiol 2001; 37:1042-1048. (Pubitemid 32217604)
27. Bella JN, Palmieri V, Roman MJ, Liu JE, Welty TK, Lee ET, Fabsitz RR, Howard BV, Devereux RB. Mitra ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study Circulation 2002; 105:1928-1933. (Pubitemid 34437620)
28. Galderisi M. Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects. Cardiovasc Ultrasound 2005; 3:9.
29. Wang M, Yip GW, Wang AY, Zhang Y, Ho PY, Tse MK, Yu CM, Sanderson JE. Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy. J Hypertens 2005; 23: 183-191. (Pubitemid 40128997)
30. Dokainish H, Zoghbi WA, Lakkis NM, Ambriz E, Patel R, Quinones MA, Nagueh SF ncremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol 2005; 45:1223-1226. (Pubitemid 40523141)
31. Caiati C, Montaldo C, Zedda N, Bina A, Iliceto S. New noninvasive method for coronary flow reserve assessment: contrast-enhanced transthoracic second harmonic echo Doppler. Circulation 1999; 99:771-778. (Pubitemid 29083017)
32. Pizzuto F, Voci P, Mariano E, Puddu PE, Sardella G, Nigri A. Assessment of flow velocity reserve by transthoracic Doppler echocardiography and venous adenosine infusion before and after left anterior descending coronary artery stenting J Am Coll Cardiol 2001; 38:155-162. (Pubitemid 32613843)
33. Rigo F, Richieri M, Pasanisi E, Cutaia V, Zanella C, Della Valentina P Di Pede F, Raviele A, Picano E. Usefulness of coronary flow reserve over regional wall motion when added to dual-imaging dipyridamole echocardiography Am J Cardiol 2003; 91:269-273. (Pubitemid 36143864)
34. Galderisi M, de Simone G, D'Errico A, Sidiropulos M, Viceconti R, Chinali M, Mondillo S, de Divitiis O. Independent association of coronary flow reserve with left ventricular relaxation and filling pressure in arterial hypertension. Am J Hypertens 2008; 21:1040-1046.
35. Masuyama T, Uematsu M, Doi Y, Yamamoto K, Mano T, Naito J, Kondo H, Nagano R, Hori M, Kamada T Abnormal coronary flow dynamics at rest and during tachycardia associated with impaired left ventricular relaxation in humans: mplication for tachycardia-induced myocardial ischemia. J Am Coll Cadiol 1994; 24:1625-1632. (Pubitemid 24369185)
36. Galderisi M, Caso P, Cicala S, De Simone L, Barbieri M, Vitale G, de Divitiis O, Paolisso G. Positive association between circulating free insulin-like growth factor-1 levels and coronary flow reserve in arterial systemic hypertension. Am J Hypertens 2002; 15:766-772. (Pubitemid 34970104)
37. Devereux RB, de Simone G, Palmieri V, Oberman A, Hopkins P, Kitzman DW, Rao DC, Arnett DK. Relation of insulin to left ventricular geometry and function in African American and white hypertensive adults: the HyperGEN study. Am J Hypertens 2002; 15:1029-1035. (Pubitemid 35397535)
38. Galderisi M, Capaldo B, Sidiropulos M, D'Errico A, Ferrara L, Turco A, Guarini P Riccardi G, de Divitiis O. Determinants of reduction of coronary flow reserve in pa h type 2 diabetes mellitus or arterial hypertension without angiographically determined epicardial coronary stenosis. Am J Hypertens 2007; 20:1283-1290. (Pubitemid 350161828)
39. de Simone G, Kitzman DW, Palmieri V, Liu JE, Oberman A, Hopkins PN, Bella JN, Rao DC, Arnett DK, Devereux RB. Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: the HyperGEN study. Am J Hypertens 2004; 17:828-833. (Pubitemid 39201100)
40. Frohlich ED. AT1 receptors: coronary flow and flow reserve. Am J Hypertens 2000;13:39S-44S. (Pubitemid 30103854)
41. Sciarretta S, Paneni F, Palano F, Chin D, Tocci G, Rubattu S, Volpe M. Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. Clin Sci 2009; 116: 467-477.
42. Egashira K, Suzuki S, Hirooka Y, Kai H, Sugimachi M, Imaizumi T, Takeshita A. mpaired endotheliumdependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Different responses to acetylcholine and substance P. Hypertension 1995; 25:201-206.
43. Paulus WJ, Shah AM. NO and cardiac diastolic function. Cardiovasc Res 1999; 43:595-606. (Pubitemid 29369258)
44. Eren M, Gorgulu S, Uslu N, Celik S, Dagdeviren B, Tezel T Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both. Heart 2004; 90:37-43. (Pubitemid 38064540)
45. Mottram PM, Haluska BA, Leano R, Carlier S, Case C, Marwick TH. Relation of arterial stiffness to diastolic dysfunction in hypertensive heart disease. Heart 2005; 91:1551-1556. (Pubitemid 41697593)
46. Abhayaratna WP, Barnes ME, O'Rourke MF, Gersh BJ, Seward JB, Miyasaka Y, Bailey KR, Tsang TS. Relation of arterial stiffness to left ventricular diastolic function and cardiovascular risk prediction in patients < or =65 years of age. Am J Cadiol 2006; 98:1387-1392. (Pubitemid 44666649)
47. Lantelme P Laurent S, Besnard C, Bricca G, Vincent M, Legedz L, Milon H. Arteria stiffness is associated with left atrial size in hypertensive patients. Arch Cardiovasc Dis 2008; 101:35-40. (Pubitemid 351462756)
48. Abhayaratna WP, Srikusalanukul W, Budge MM. Aortic stiffness for the detection of preclinical left ventricular diastolic dysfunction: pulse wave velocity vs. pulse pressure. J Hypertens 2008; 26:758-764. (Pubitemid 351354924)
49. Kawaguchi M, Hay I, Fetics B, Kass DA. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: mplications for systolic and diastolic reserve imitations. Circulation 2003; 107:714-720. (Pubitemid 36222599)
50. Lam CS, Roger VL, Rodeheffer RJ, Bursi F, Borlaug BA, Ommen SR, Kass DA, Redfield MM. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 2007; 115:1982-1990. (Pubitemid 46625948)
51. Westermann D, Kasner M, Steendijk P, Spillmann F, Riad A, Weitmann K, Hoffmann W, Poller W, Pauschinger M, Schultheiss HP, Tschöpe C Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation 2008; 117:2051-2060. (Pubitemid 351572179)
52. Antonini-Canterin F, Carerj S, Di Bello V, Di Salvo G, La Carrubba S, Vriz O, Pavan D, Balbarini A, Nicolosi GL; Research Group of the Italian Society of Cardiovascular Echography (SIEC). Arteria stiffness and ventricular stiffness: a couple diseases or a coupling disease? A review from the cardiologist's point of view. Eur J Echocardiogr 2009; 10:36-43.
53. de Simone G, Greco R, Mureddu GF, Romano C, Guida R, Celentano A, Contaldo F. Relation of left ventricular diastolic properties to systolic function in arteria hypertension. Circulation 2001;101:152-157.
54. Wachtell K, Papademetriou V, Smith G, Gerdts E, Dahlöf B, Engblom E, Aurigemma GP, Bella JN, Ibsen H, Rokkedal J, Devereux RB. Relation of impaired eft ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study. Am Heart J 2004; 148:538-544. (Pubitemid 39265131)
55. Galderisi M, Lomoriello VS, Santoro A, Esposito R, Olibet M, Raia R, Dario Di Minno MN, Guerra G, Mele D, Lombardi G. Differences of myocardia systolic deformation and correlates of diastolic function in competitive rowers and young hype le-tracking echocardiography study. J Am Soc Echocardiogr 2010; 23:1190-1198.
56. Di Bello V, Talini E, Dell'Omo G, Giannini C, Delle Donne MG, Canale ML, Nardi C, Palagi C, Dini FL, Penno G, De Prato S, Marzilli M, Pedrinelli R. Early left ventricular mechanics abnormalities in prehypertension: a two-dimensional strain echocardiography study. Am J Hypertens 2010; 23:405-412.
57. Yu CM, Lin H, Yang H, Kong SL, Zhang Q, Lee SW. Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction. Circulation 2002; 105:1195-1201. (Pubitemid 34225820)
58. Yip G, Wang M, Zhang Y Fung JW, Ho PY, Sanderson JE. Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition? Heart 2002; 87:121-125. (Pubitemid 34098370)
59. Wang J, Khoury DS, Yue Y, Torre-Amione G, Nagueh SF. Preserved left ventricular twist and circumferentia deformation, but depressed longitudinal and radia deformation in patients with diastolic heart failure. Eur Heart J 2008; 29: 1283-1289. (Pubitemid 351768130)
60. Park SJ, Miyazaki C, Bruce CJ, Ommen S, Miller FA, Oh JK. Left ventricular torsion by two-dimensional speckle tracking echocardiography in patients with diastolic dysfunction and normal ejection fraction J Am Soc Echocardiogr 2008; 21: 1129-1137.
61. Kosmala W, Plaksej R, Strotmann JM, Weigel C, Herrmann S, Niemann M, Mende H, Störk S, Angermann CE, Wagner JA, Weidemann F. Progression of left ventricular functional abnormalities in hypertensive patients with heart failure: an ultrasonic two-dimensional speckle tracking study. J Am Soc Echocardiogr 2008; 21: 1309-1317.
62. Cho GY, Marwick TH, Kim HS, Kim MK, Hong KS, Oh DJ. Global 2-dimensiona strain as a new prognosticator in patients with heart failure. J Am Coll Cardiol 2009; 54:618-624.
63. Aronow WS. Treatment of congestive heart failure in older persons. J Am Geriatr Soc 1997; 45:1252-1257.
64. Ma TK, Kam KK, Yan BP, Lam YY Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol 2010; 160:1273-1292.
65. Meng G, Wu F, Yang L, Zhu H, Gu J, He M, Xu J. Synergistic attenuation of myocardial fibrosis in spontaneously hypertensive rats by joint treatment with benazepril and candesarta J Cardiovasc Pharmacol 2009; 54:16-24.
66. Mizuta Y, Kai H, Mizoguchi M, Osada K, Tahara N, Nakaura H, Kuwahara F, maizumi T; Valsartan Diastolic Function Improvement Study Investigators. Long-term treatment with valsartan improved cyclic variation of the myocardia ntegral backscatter signal and diastolic dysfunction in hypertensive patients: the echocardiographic assessment Hypertens Res 2008; 31:1835-1842.
67. Müller-Brunotte R, Kahan T, López B, Edner M, González A, Díez J, Malmqvist K Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA). J Hyperten 5:1958-1966.
68. Müller-Brunotte R, Kahan T, Malmqv K, Ring M, Edner M. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA). Am J Hypertens 2006; 19:927-936. (Pubitemid 46106993)
69. Mattioli AV, Zennaro M, Bonatti S, Bonetti L, Mattioli G. Regression of left ventricular hypertrophy and improvement of diastolic function in hypertensive patients treated with telmisartan. Int J Cardiol 2004; 97:383-388. (Pubitemid 39550684)
70. Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayastha D, Lacourcière Y, Hippler SE, Fields H, Naqvi TZ, Mulvagh SL, Arnold JM, Thomas JD, Zile MR, Aurigemma GP; Valsartan In Diastolic Dysfunction (VALIDD) Investigators. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet 2007; 369:2079-2087. (Pubitemid 46935945)
71. Yip GW, Wang M, Wang T, Chan S, Fung JW, Yeung L, Yip T Lau ST, Lau CP, Tang MO, Yu CM, Sanderson JE. The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejectio fraction. Heart 2008; 94:573-580. (Pubitemid 351580128)
72. Whaley-Connell A, Habibi J, Cooper SA, Demarco VG, Hayden MR, Stump CS, Link D, Ferrario CM, Sowers JR. Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat. Am J Physiol Endocrinol Metab 2008; 295:E103-E109.
73. Solomon SD, Appelbaum E, Manning WJ, Verma A, Berglund T, Lukashevich V, Cherif Papst C, Smith BA, Dahlöf B; Aliskiren in Left Ventricular Hypertrophy (ALLAY) Trial Investigators. Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy Circulation 2009; 119: 530-537.
74. Brilla CG, Maisch B, Zhou G, Weber KT Hormonal regulation of cardiac fibroblast function. Eur Heart J 1995; 16 Suppl C:45-50.
75. Grandi AM, Imperiale D, Santillo R, Barlocco E, Bertolini A, Guasti L, Venco A. Aldosterone antagonist improves diastolic function in essential hypertension. Hypertension 2002; 40:647-652. (Pubitemid 35278600)
76. Mak GJ, Ledwidgen CJ, Phelan DM, Dawkins IR, Murphy NF, Patle AK, Baugh JA, McDonald KM. N tural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone. J Am Coll Cardiol 2009; 54:1674-1682.
77. Hung MJ, Cherng WJ, Wang CH, Kuo LT Effects of verapamil in normal elderly ndividuals with left ventricular diastolic dysfunction. Echocardiography 2001; 18:123-129.
78. Müller-Brunotte R, Edner M, Malmqvist K, Kahan T Irbesartan and atenolo mprove diastolic function in patients with hypertensive left ventricular hypertrophy. J Hypertens 2005; 23:633-640. (Pubitemid 40684723)
79. Bergström A, Andersson B, Edner M, Nylander E, Persson H, Dahlström U. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). Eur J Heart Fail 2004; 6:453-461. (Pubitemid 38746589)
80. Nodari S, Metra M, Dei Cas L β-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the ong-term effects of atenolol vs. nebivolol. Eur J Heart Fail 2003; 5:621-627. (Pubitemid 38043967)
81. Mahmud A, Feely J. β-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection. Am J Hypertens 2008; 21: 663-667. (Pubitemid 351733365)
82. Galderisi M, D'Errico A, Sidiropulos M, Innelli P, de Divitiis O, de Simone G. Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension. J Hypertens 2009; 27:2108-2115.
83. Biria M, Howard PA, Vacek J. Do statins have a role in the management of diastolic dysfunction? Am J Cardiovasc Drugs 2008; 8:297-303.
84. Milliez P Messaoudi S, Nehme J, Rodriguez C, Samuel JL, Delcayre C. Beneficia effects of delayed ivabradine treatment on cardiac anatomical and electrica remodeling in rat severe chronic heart failure. Am J Physiol Heart Circ Physiol 2009; 296:H435-H441.
85. Sossalla S, Wagner S, Rasenack EC, Ruff H, Weber SL, Schöndube FA, Tirilomis T, Tenderich G, Hasenfuss G, Belardinelli L, Maier LS. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts-role of late sodium current and intracellular ion accumulation. J Mol Cell Cardiol 2008; 45: 32-43.
86. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-533.
87. Dobre D, van Veldhuisen DJ, DeJongste MJ, Lucas C, Cleuren G, Sanderman R, Ranchor AV, Haaijer-Ruskamp FM. Prescription of β-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinica mplications and survival. Eur J Heart Fail 2007; 9:280-286. (Pubitemid 46330137)
88. Massie BM, Nelson JJ, Lukas MA, Greenberg B, Fowler MB, Gilbert EM, Abraham WT, Lottes SR, Franciosa JA; COHERE Participant Physicians. Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice. Am J Cardiol 2007 1268.
89. Tribouilloy C, Rusinaru D, Leborgne L, Peltier M, Massy Z, Slama M. Prognosticmpact of angiotensin-converting enzyme inhibitor therapy in diastolic heart failure. Am J Cardiol 2008; 101:639-644. (Pubitemid 351625089)
90. Hernandez AF, Hammill BG, O'Connor CM, Schulman KA, Curtis LH, Fonarow GC Clinical effectiveness of β-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry ardiol 2009; 53:184-192.
91. Carson P, Johnson G, Fletcher R, Cohn J. Mild systolic dysfunction in heart failure (left ventricular ejection fraction <35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT) J Am Coll Cardiol 1996; 27:642-649.
92. Ghio S, Magrini G, Serio A, Klersy C, Fucili A, Fucilli A, Ronaszèki A, Karpati P, Mordenti G, Capriati A, Poole-Wilson PA, Tavazzi L; SENIORS investigators. Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy Eur Heart J 2006; 27:562-568.
93. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Gu elines and Standards Committee; European Association of Ech cardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 2005; 18:1440-1463. (Pubitemid 41821197)
94. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003; 362:777-781. (Pubitemid 37093918)
95. Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J; PEP-CHF nvestigators. The perindopril in elderly people with chronic heart failure (PEP-CHF) study Eur Heart J 2006; 27:2338-2345. (Pubitemid 44453578)
96. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A; I-PRESERVE Investigators. rbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008; 359:2456-2467.
97. Paulus WJ, van Ballegoij JJ. Treatment of heart failure with normal ejection fraction: an inconvenient truth! J Am Coll Cardiol 2010; 55:526-537.
98. Almuntaser I, Mahmud A, Brown A, Murphy R, King G, Crean P Feely J. Blood pressure control determines improvement in diastolic dysfunction in early hypertension. Am J Hypertens 2009; 22:1227-1231.
99. Solomon SD, Verma A Desai A, Hassanein A, Izzo J, Oparil S, Lacourciere Y, Lee J, Seifu Y, Hilkert RJ, Rocha R, Pitt B; Exforge Intensive Control of Hypertension to Evaluate Efficacy in Diastolic Dysfunction Investigators. Effect of intensive vs. standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction. Hypertension 2010; 55: 241-248.
100. Strauer BE, Schwartzkopff B. Objectives of high blood pressure treatment: left ventricular hypertrophy, diastolic function, and coronary reserve. Am J Hypertens 1998; 11:879-881. (Pubitemid 28351026)
101. Wachtell K, Dahlöf B, Rokkedal J, Papademetriou V, Nieminen MS, Smith G, Gerdts E, Boman K, Bella JN, Devereux RB. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Am Heart J 2002; 144: 1057-1064. (Pubitemid 36026920)